Vega 100mg Research Overview
Vega 100mg is a phosphodiesterase type 5 (PDE5) inhibitor manufactured by Signature Pharmaceuticals Ltd., containing sildenafil citrate as the active compound. This research-grade formulation enables laboratory investigations into nitric oxide-cyclic guanosine monophosphate (NO-cGMP) signaling pathways and vascular smooth muscle cell responses in controlled experimental environments. Researchers can examine the molecular mechanisms underlying PDE5 enzyme inhibition and its downstream effects on intracellular signaling cascades.
Laboratory Research Applications
Scientists frequently utilise sildenafil citrate preparations like Vega 100mg to investigate endothelial dysfunction models and vascular biology research protocols. The compound serves as a valuable research tool for studying phosphodiesterase enzyme kinetics, examining cellular responses to PDE5 modulation, and analysing nitric oxide pathway interactions in tissue culture systems. Laboratory studies have explored sildenafil’s effects on pulmonary arterial pressure mechanisms, making it relevant for cardiovascular research applications alongside other compounds available through Stroid UK Shop. Researchers investigating complementary pathways often cross-reference findings with studies involving SARMs for tissue-selective effects or peptides for growth factor signaling research. Within the broader category of sildenafil citrate research compounds, Vega 100mg provides consistent dosing for experimental reproducibility.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength | 100mg per tablet |
| Manufacturer | Signature Pharmaceuticals Ltd. |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| CAS Number | 171599-83-0 |
| Storage Conditions | Room temperature, dry environment |
| Solubility | Water soluble (citrate salt) |
Research Compliance Statement
Vega 100mg tablets are manufactured exclusively for in-vitro laboratory research applications and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must handle this compound according to institutional safety protocols and applicable regulatory guidelines. All experimental work should be conducted by qualified personnel in appropriate laboratory facilities with proper safety equipment and documentation procedures.
